These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30203447)

  • 1. Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications.
    Russell AL; Lefavor RC; Zubair AC
    Transfusion; 2018 Oct; 58(10):2374-2382. PubMed ID: 30203447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system.
    Rojewski MT; Fekete N; Baila S; Nguyen K; Fürst D; Antwiler D; Dausend J; Kreja L; Ignatius A; Sensebé L; Schrezenmeier H
    Cell Transplant; 2013; 22(11):1981-2000. PubMed ID: 23107560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive characterisation of large-scale expanded human bone marrow and umbilical cord mesenchymal stem cells.
    Mennan C; Garcia J; Roberts S; Hulme C; Wright K
    Stem Cell Res Ther; 2019 Mar; 10(1):99. PubMed ID: 30885254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
    Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
    Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor.
    Nold P; Brendel C; Neubauer A; Bein G; Hackstein H
    Biochem Biophys Res Commun; 2013 Jan; 430(1):325-30. PubMed ID: 23146633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.
    Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM
    Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culture expansion of adipose derived stromal cells. A closed automated Quantum Cell Expansion System compared with manual flask-based culture.
    Haack-Sørensen M; Follin B; Juhl M; Brorsen SK; Søndergaard RH; Kastrup J; Ekblond A
    J Transl Med; 2016 Nov; 14(1):319. PubMed ID: 27852267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System.
    Hanley PJ; Mei Z; Durett AG; Cabreira-Hansen Mda G; Klis M; Li W; Zhao Y; Yang B; Parsha K; Mir O; Vahidy F; Bloom D; Rice RB; Hematti P; Savitz SI; Gee AP
    Cytotherapy; 2014 Aug; 16(8):1048-58. PubMed ID: 24726657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Marrow Mesenchymal Stromal Cells from Clinical Scale Culture: In Vitro Evaluation of Their Differentiation, Hematopoietic Support, and Immunosuppressive Capacities.
    Fajardo-Orduña GR; Mayani H; Castro-Manrreza ME; Flores-Figueroa E; Flores-Guzmán P; Arriaga-Pizano L; Piña-Sánchez P; Hernández-Estévez E; Castell-Rodríguez AE; Chávez-Rueda AK; Legorreta-Haquet MV; Santiago-Osorio E; Montesinos JJ
    Stem Cells Dev; 2016 Sep; 25(17):1299-310. PubMed ID: 27462977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results.
    Savelli S; Trombi L; D'Alessandro D; Moscato S; Pacini S; Giannotti S; Lapi S; Scatena F; Petrini M
    Cytotherapy; 2018 Apr; 20(4):556-563. PubMed ID: 29429942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-Scale Automated Hollow-Fiber Bioreactor Expansion of Umbilical Cord-Derived Human Mesenchymal Stromal Cells for Neurological Disorders.
    Vymetalova L; Kucirkova T; Knopfova L; Pospisilova V; Kasko T; Lejdarova H; Makaturova E; Kuglik P; Oralova V; Matalova E; Benes P; Koristek Z; Forostyak S
    Neurochem Res; 2020 Jan; 45(1):204-214. PubMed ID: 31828497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers.
    Phinney DG; Galipeau J;
    Cytotherapy; 2019 Jul; 21(7):782-792. PubMed ID: 31182333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells.
    Manochantr S; Tantrawatpan C; Kheolamai P; U-pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S183-91. PubMed ID: 21294413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions.
    Santos Fd; Andrade PZ; Abecasis MM; Gimble JM; Chase LG; Campbell AM; Boucher S; Vemuri MC; Silva CL; Cabral JM
    Tissue Eng Part C Methods; 2011 Dec; 17(12):1201-10. PubMed ID: 21895491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system.
    Eibes G; dos Santos F; Andrade PZ; Boura JS; Abecasis MM; da Silva CL; Cabral JM
    J Biotechnol; 2010 Apr; 146(4):194-7. PubMed ID: 20188771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
    Bakopoulou A; Apatzidou D; Aggelidou E; Gousopoulou E; Leyhausen G; Volk J; Kritis A; Koidis P; Geurtsen W
    Stem Cell Res Ther; 2017 Nov; 8(1):247. PubMed ID: 29096714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.
    Li CY; Wu XY; Tong JB; Yang XX; Zhao JL; Zheng QF; Zhao GB; Ma ZJ
    Stem Cell Res Ther; 2015 Apr; 6(1):55. PubMed ID: 25884704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GMP-Compliant Expansion of Clinical-Grade Human Mesenchymal Stromal/Stem Cells Using a Closed Hollow Fiber Bioreactor.
    Barckhausen C; Rice B; Baila S; Sensebé L; Schrezenmeier H; Nold P; Hackstein H; Rojewski MT
    Methods Mol Biol; 2016; 1416():389-412. PubMed ID: 27236685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.